Langerhans cells-programmed by the epidermis

Frontiers in Immunology

Volumn 8, Issue NOV, 2017, Pages

  Clayton, Kalum ^a   Vallejo, Andres F ^a   Davies, James ^a   Sirvent, Sofia ^a   Polak, Marta E ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cross presentation; Dendritic cells; Epidermis; Gene regulatory networks; Immune regulation; Langerhans cells; Macrophages; Transcription factors

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF DIFFERENTIATION 2; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 12P70; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; STAT5 PROTEIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLL LIKE RECEPTOR 3; TRANSCRIPTION FACTOR RUNX3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ANTIGEN PRESENTATION; CELL MATURATION; CELLULAR IMMUNITY; COMPUTER MODEL; CONVERGENT EVOLUTION; EPIDERMIS; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETIC ANALYSIS; HISTONE MODIFICATION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INNATE IMMUNITY; LANGERHANS CELL; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION; TRANSCRIPTOMICS;

EID: 85036523475     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01676     Document Type: Review

References (127)

1. Heath WR, Carbone FR. The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat Immunol (2013) 14(10):978-85. doi:10.1038/ni.2680
2. Clausen BE, Kel JM. Langerhans cells: critical regulators of skin immunity? Immunol Cell Biol (2010) 88(4):351-60. doi:10.1038/icb.2010.40
3. Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med (2009) 206(13):2937-46. doi:10.1084/jem.20091527
4. Seneschal J, Clark RA, Gehad A, Baecher-Allan CM, Kupper TS. Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity (2012) 36(5):873-84. doi:10.1016/j.immuni.2012.03.018
5. van der Aar AM, Picavet DI, Muller FJ, de Boer L, van Capel TM, Zaat SA, et al. Langerhans cells favor skin flora tolerance through limited presentation of bacterial antigens and induction of regulatory T cells. J Invest Dermatol (2013) 133(5):1240-9. doi:10.1038/jid.2012.500
6. Polak ME, Newell L, Taraban VY, Pickard C, Healy E, Friedmann PS, et al. CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells. J Invest Dermatol (2012) 132(6):1636-44. doi:10.1038/jid.2012.26
7. Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson-Snipes L, et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity (2008) 29(3):497-510. doi:10.1016/j.immuni.2008.07.013
8. Groves RW, Allen MH, Ross EL, Barker JN, MacDonald DM. Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol (1995) 132(3):345-52. doi:10.1111/j.1365-2133.1995.tb08666.x
9. Cumberbatch M, Kimber I. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology (1992) 75(2):257-63
10. Kimber I, Cumberbatch M. Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alpha). J Invest Dermatol (1992) 99(5):48S-50S. doi:10.1111/1523-1747.ep12668986
11. Nishibu A, Ward BR, Jester JV, Ploegh HL, Boes M, Takashima A. Behavioral responses of epidermal Langerhans cells in situ to local pathological stimuli. J Invest Dermatol (2006) 126(4):787-96. doi:10.1038/sj.jid.5700107
12. Polak ME, Thirdborough SM, Ung CY, Elliott T, Healy E, Freeman TC, et al. Distinct molecular signature of human skin Langerhans cells denotes critical differences in cutaneous dendritic cell immune regulation. J Invest Dermatol (2014) 134(3):695-703. doi:10.1038/jid.2013.375
13. Polak ME, Ung CY, Masapust J, Freeman TC, Ardern-Jones MR. Petri Net computational modelling of Langerhans cell interferon regulatory factor network predicts their role in T cell activation. Sci Rep (2017) 7(1):668. doi:10.1038/s41598-017-00651-5
14. Ebner S, Nguyen VA, Forstner M, Wang YH, Wolfram D, Liu YJ, et al. Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells. J Allergy Clin Immunol (2007) 119(4):982-90. doi:10.1016/j.jaci.2007.01.003
15. Kel JM, Girard-Madoux MJ, Reizis B, Clausen BE. TGF-beta is required to maintain the pool of immature Langerhans cells in the epidermis. J Immunol (2010) 185(6):3248-55. doi:10.4049/jimmunol.1000981
16. Mohammed J, Beura LK, Bobr A, Astry B, Chicoine B, Kashem SW, et al. Stromal cells control the epithelial residence of DCs and memory T cells by regulated activation of TGF-beta. Nat Immunol (2016) 17(4):414-21. doi:10.1038/ni.3396
17. Schuster C, Vaculik C, Prior M, Fiala C, Mildner M, Eppel W, et al. Phenotypic characterization of leukocytes in prenatal human dermis. J Invest Dermatol (2012) 132(11):2581-92. doi:10.1038/jid.2012.187
18. Ghigo C, Mondor I, Jorquera A, Nowak J, Wienert S, Zahner SP, et al. Multicolor fate mapping of Langerhans cell homeostasis. J Exp Med (2013) 210(9):1657-64. doi:10.1084/jem.20130403
19. Hemmerling J, Wegner-Kops J, von Stebut E, WolffD, Wagner EM, Hartwig UF, et al. Human epidermal Langerhans cells replenish skin xenografts and are depleted by alloreactive T cells in vivo. J Immunol (2011) 187(3):1142-9. doi:10.4049/jimmunol.1001491
20. Kanitakis J, Morelon E, Petruzzo P, Badet L, Dubernard JM. Self-renewal capacity of human epidermal Langerhans cells: observations made on a composite tissue allograft. Exp Dermatol (2011) 20(2):145-6. doi:10.1111/j.1600-0625.2010.01146.x
21. Kanitakis J, Petruzzo P, Dubernard JM. Turnover of epidermal Langerhans' cells. N Engl J Med (2004) 351(25):2661-2. doi:10.1056/NEJM200412163512523
22. Sere K, Baek JH, Ober-Blobaum J, Muller-Newen G, Tacke F, Yokota Y, et al. Two distinct types of Langerhans cells populate the skin during steady state and inflammation. Immunity (2012) 37(5):905-16. doi:10.1016/j.immuni.2012.07.019
23. Cavani A, Mei D, Guerra E, Corinti S, Giani M, Pirrotta L, et al. Patients with allergic contact dermatitis to nickel and nonallergic individuals display different nickel-specific T cell responses. Evidence for the presence of effector CD8+ and regulatory CD4+ T cells. J Invest Dermatol (1998) 111(4):621-8. doi:10.1046/j.1523-1747.1998.00334.x
24. Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol (2000) 114(2):295-302. doi:10.1046/j.1523-1747.2000.00881.x
25. Cooper KD, Oberhelman L, Hamilton TA, Baadsgaard O, Terhune M, LeVee G, et al. UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc Natl Acad Sci U S A (1992) 89(18):8497-501. doi:10.1073/pnas.89.18.8497
26. Kreutz M, Karrer S, Hoffmann P, Gottfried E, Szeimies RM, Hahn J, et al. Whole-body UVB irradiation during allogeneic hematopoietic cell transplantation is safe and decreases acute graft-versus-host disease. J Invest Dermatol (2012) 132(1):179-87. doi:10.1038/jid.2011.255
27. Newell L, Polak ME, Perera J, Owen C, Boyd P, Pickard C, et al. Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis. J Invest Dermatol (2013) 133(10):2372-80. doi:10.1038/jid.2013.148
28. Sabatos-Peyton CA, Verhagen J, Wraith DC. Antigen-specific immunotherapy of autoimmune and allergic diseases. Curr Opin Immunol (2010) 22(5):609-15. doi:10.1016/j.coi.2010.08.006
29. Ring S, Maas M, Nettelbeck DM, Enk AH, Mahnke K. Targeting of autoantigens to DEC205+ dendritic cells in vivo suppresses experimental allergic encephalomyelitis in mice. J Immunol (2013) 191(6):2938-47. doi:10.4049/jimmunol.1202592
30. Combadiere B, Vogt A, Mahe B, Costagliola D, Hadam S, Bonduelle O, et al. Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial. PLoS One (2010) 5(5):e10818. doi:10.1371/journal.pone.0010818
31. Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med (2004) 351(22):2295-301. doi:10.1056/NEJMoa043540
32. Zhao X, Deak E, Soderberg K, Linehan M, Spezzano D, Zhu J, et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med (2003) 197(2):153-62. doi:10.1084/jem.20021109
33. Ritter U, Meissner A, Scheidig C, Korner H. CD8 alpha-and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur J Immunol (2004) 34(6):1542-50. doi:10.1002/eji.200324586
34. Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML, et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol (2005) 169(4):569-76. doi:10.1083/jcb.200501071
35. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity (2005) 23(6):611-20. doi:10.1016/j.immuni.2005.10.008
36. Banchereau J, Thompson-Snipes L, Zurawski S, Blanck JP, Cao Y, Clayton S, et al. The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming. Blood (2012) 119(24):5742-9. doi:10.1182/blood-2011-08-371245
37. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature (1998) 392(6673):245-52. doi:10.1038/32588
38. Wu L, Liu YJ. Development of dendritic-cell lineages. Immunity (2007) 26(6):741-50. doi:10.1016/j.immuni.2007.06.006
39. Doebel T, Voisin B, Nagao K. Langerhans cells-the macrophage in dendritic cell clothing. Trends Immunol (2017) 38(11):817-28. doi:10.1016/j.it.2017.06.008
40. Silberberg I, Baer RL, Rosenthal SA. The role of Langerhans cells in allergic contact hypersensitivity. A review of findings in man and guinea pigs. J Invest Dermatol (1976) 66(4):210-7. doi:10.1111/1523-1747.ep12482139
41. Ober-Blobaum JL, Ortner D, Haid B, Brand A, Tripp C, Clausen BE, et al. Monitoring skin dendritic cells in steady state and inflammation by immunofluorescence microscopy and flow cytometry. Methods Mol Biol (2017) 1559:37-52. doi:10.1007/978-1-4939-6786-5_3
42. Bajana S, Roach K, Turner S, Paul J, Kovats S. IRF4 promotes cutaneous dendritic cell migration to lymph nodes during homeostasis and inflammation. J Immunol (2012) 189(7):3368-77. doi:10.4049/jimmunol.1102613
43. Shklovskaya E, Roediger B, Fazekas de St Groth B. Epidermal and dermal dendritic cells display differential activation and migratory behavior while sharing the ability to stimulate CD4+ T cell proliferation in vivo. J Immunol (2008) 181(1):418-30. doi:10.4049/jimmunol.181.1.418
44. Duluc D, Banchereau R, Gannevat J, Thompson-Snipes L, Blanck JP, Zurawski S, et al. Transcriptional fingerprints of antigen-presenting cell subsets in the human vaginal mucosa and skin reflect tissue-specific immune microenvironments. Genome Med (2014) 6(11):98. doi:10.1186/s13073-014-0098-y
45. Lavin Y, Winter D, Blecher-Gonen R, David E, Keren-Shaul H, Merad M, et al. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell (2014) 159(6):1312-26. doi:10.1016/j.cell.2014.11.018
46. Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann NJ, et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell (2014) 159(6):1327-40. doi:10.1016/j.cell.2014.11.023
47. Heidkamp GF, Sander J, Lehmann CHK, Heger L, Eissing N, Baranska A, et al. Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment. Sci Immunol (2016) 1(6):eaai7677. doi:10.1126/sciimmunol.aai7677
48. Carpentier S, Vu Manh TP, Chelbi R, Henri S, Malissen B, Haniffa M, et al. Comparative genomics analysis of mononuclear phagocyte subsets confirms homology between lymphoid tissue-resident and dermal XCR1(+) DCs in mouse and human and distinguishes them from Langerhans cells. J Immunol Methods (2016) 432:35-49. doi:10.1016/j.jim.2016.02.023
49. Miller JC, Brown BD, Shay T, Gautier EL, Jojic V, Cohain A, et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat Immunol (2012) 13(9):888-99. doi:10.1038/ni.2370
50. Mabbott NA, Kenneth Baillie J, Hume DA, Freeman TC. Meta-analysis of lineage-specific gene expression signatures in mouse leukocyte populations. Immunobiology (2010) 215(9-10):724-36. doi:10.1016/j.imbio.2010.05.012
51. Santegoets SJ, Gibbs S, Kroeze K, van de Ven R, Scheper RJ, Borrebaeck CA, et al. Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions. J Leukoc Biol (2008) 84(1):143-51. doi:10.1189/jlb.1107750
52. Ribeiro CM, Sarrami-Forooshani R, Setiawan LC, Zijlstra-Willems EM, van Hamme JL, Tigchelaar W, et al. Receptor usage dictates HIV-1 restriction by human TRIM5alpha in dendritic cell subsets. Nature (2016) 540(7633):448-52. doi:10.1038/nature20567
53. de Witte L, Nabatov A, Geijtenbeek TB. Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission. Trends Mol Med (2008) 14(1):12-9. doi:10.1016/j.molmed.2007.11.001
54. Munz C, Dao T, Ferlazzo G, de Cos MA, Goodman K, Young JW. Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. Blood (2005) 105(1):266-73. doi:10.1182/blood-2004-06-2492
55. Ratzinger G, Baggers J, de Cos MA, Yuan J, Dao T, Reagan JL, et al. Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells. J Immunol (2004) 173(4):2780-91. doi:10.4049/jimmunol.173.4.2780
56. Flacher V, Tripp CH, Mairhofer DG, Steinman RM, Stoitzner P, Idoyaga J, et al. Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance. EMBO Mol Med (2014) 6:1191-204. doi:10.15252/emmm.201303283
57. van der Aar AM, de Groot R, Sanchez-Hernandez M, Taanman EW, van Lier RA, Teunissen MB, et al. Cutting edge: virus selectively primes human Langerhans cells for CD70 expression promoting CD8+ T cell responses. J Immunol (2011) 187(7):3488-92. doi:10.4049/jimmunol.1101105
58. Klechevsky E, Flamar AL, Cao Y, Blanck JP, Liu M, O'Bar A, et al. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR. Blood (2010) 116(10):1685-97. doi:10.1182/blood-2010-01-264960
59. Fujita H, Nograles KE, Kikuchi T, Gonzalez J, Carucci JA, Krueger JG. Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc Natl Acad Sci U S A (2009) 106(51):21795-800. doi:10.1073/pnas.0911472106
60. Aliahmadi E, Gramlich R, Grutzkau A, Hitzler M, Kruger M, Baumgrass R, et al. TLR2-activated human Langerhans cells promote Th17 polarization via IL-1beta, TGF-beta and IL-23. Eur J Immunol (2009) 39(5):1221-30. doi:10.1002/eji.200838742
61. Cunningham AL, Carbone F, Geijtenbeek TB. Langerhans cells and viral immunity. Eur J Immunol (2008) 38(9):2377-85. doi:10.1002/eji.200838521
62. Kim M, Truong NR, James V, Bosnjak L, Sandgren KJ, Harman AN, et al. Relay of herpes simplex virus between Langerhans cells and dermal dendritic cells in human skin. PLoS Pathog (2015) 11(4):e1004812. doi:10.1371/journal.ppat.1004812
63. van der Vlist M, Geijtenbeek TB. Langerin functions as an antiviral receptor on Langerhans cells. Immunol Cell Biol (2010) 88(4):410-5. doi:10.1038/icb.2010.32
64. de Jong MA, de Witte L, Taylor ME, Geijtenbeek TB. Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function. J Immunol (2010) 185(3):1633-41. doi:10.4049/jimmunol.0904137
65. Puttur FK, Fernandez MA, White R, Roediger B, Cunningham AL, Weninger W, et al. Herpes simplex virus infects skin gamma delta T cells before Langerhans cells and impedes migration of infected Langerhans cells by inducing apoptosis and blocking E-cadherin downregulation. J Immunol (2010) 185(1):477-87. doi:10.4049/jimmunol.0904106
66. Artyomov MN, Munk A, Gorvel L, Korenfeld D, Cella M, Tung T, et al. Modular expression analysis reveals functional conservation between human Langerhans cells and mouse cross-priming dendritic cells. J Exp Med (2015) 212(5):743-57. doi:10.1084/jem.20131675
67. Haniffa M, Shin A, Bigley V, McGovern N, Teo P, See P, et al. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity (2012) 37(1):60-73. doi:10.1016/j.immuni.2012.04.012
68. Harman AN, Bye CR, Nasr N, Sandgren KJ, Kim M, Mercier SK, et al. Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J Immunol (2013) 190(1):66-79. doi:10.4049/jimmunol.1200779
69. Hutter C, Kauer M, Simonitsch-Klupp I, Jug G, Schwentner R, Leitner J, et al. Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells. Blood (2012) 120(26):5199-208. doi:10.1182/blood-2012-02-410241
70. Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol (2008) 8(12):935-47. doi:10.1038/nri2455
71. de Witte L, Nabatov A, Pion M, Fluitsma D, de Jong MA, de Gruijl T, et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med (2007) 13(3):367-71. doi:10.1038/nm1541
72. Singh H, Khan AA, Dinner AR. Gene regulatory networks in the immune system. Trends Immunol (2014) 35(5):211-8. doi:10.1016/j.it.2014.03.006
73. Studham ME, Tjarnberg A, Nordling TE, Nelander S, Sonnhammer EL. Functional association networks as priors for gene regulatory network inference. Bioinformatics (2014) 30(12):i130-8. doi:10.1093/bioinformatics/btu285
74. Vander Lugt B, Khan AA, Hackney JA, Agrawal S, Lesch J, Zhou M, et al. Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nat Immunol (2014) 15:161-7. doi:10.1038/ni.2795
75. Williams JW, Tjota MY, Clay BS, Vander Lugt B, Bandukwala HS, Hrusch CL, et al. Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. Nat Commun (2013) 4:2990. doi:10.1038/ncomms3990
76. Schiavoni G, Mattei F, Borghi P, Sestili P, Venditti M, Morse HC III, et al. ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood (2004) 103(6):2221-8. doi:10.1182/blood-2003-09-3007
77. Chopin M, Seillet C, Chevrier S, Wu L, Wang H, Morse HC III, et al. Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks. J Exp Med (2013) 210(13):2967-80. doi:10.1084/jem.20130930
78. Wang X, Bi Z, Wang Y, Wang Y. Increased MAPK and NF-kappaB expression of Langerhans cells is dependent on TLR2 and TLR4, and increased IRF-3 expression is partially dependent on TLR4 following UV exposure. Mol Med Rep (2011) 4(3):541-6. doi:10.3892/mmr.2011.450
79. Kraft S, Novak N, Katoh N, Bieber T, Rupec RA. Aggregation of the high-affinity IgE receptor Fc(epsilon)RI on human monocytes and dendritic cells induces NF-kappaB activation. J Invest Dermatol (2002) 118(5):830-7. doi:10.1046/j.1523-1747.2002.01757.x
80. Mathers AR, Tckacheva OA, Janelsins BM, Shufesky WJ, Morelli AE, Larregina AT. In vivo signaling through the neurokinin 1 receptor favors transgene expression by Langerhans cells and promotes the generation of Th1-and Tc1-biased immune responses. J Immunol (2007) 178(11):7006-17. doi:10.4049/jimmunol.178.11.7006
81. Clark GJ, Gunningham S, Troy A, Vuckovic S, Hart DN. Expression of the RelB transcription factor correlates with the activation of human dendritic cells. Immunology (1999) 98(2):189-96. doi:10.1046/j.1365-2567.1999.00829.x
82. Schlitzer A, McGovern N, Teo P, Zelante T, Atarashi K, Low D, et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity (2013) 38(5):970-83. doi:10.1016/j.immuni.2013.04.011
83. Tussiwand R, Lee WL, Murphy TL, Mashayekhi M, Wumesh KC, Albring JC, et al. Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature (2012) 490(7421):502-7. doi:10.1038/nature11531
84. Manh TP, Alexandre Y, Baranek T, Crozat K, Dalod M. Plasmacytoid, conventional, and monocyte-derived dendritic cells undergo a profound and convergent genetic reprogramming during their maturation. Eur J Immunol (2013) 43(7):1706-15. doi:10.1002/eji.201243106
85. Dalod M, Chelbi R, Malissen B, Lawrence T. Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming. EMBO J (2014) 33(10):1104-16. doi:10.1002/embj.201488027
86. Barbaroux JB, Beleut M, Brisken C, Mueller CG, Groves RW. Epidermal receptor activator of NF-kappaB ligand controls Langerhans cells numbers and proliferation. J Immunol (2008) 181(2):1103-8. doi:10.4049/jimmunol.181.2.1103
87. Schoppl A, Botta A, Prior M, Akgun J, Schuster C, Elbe-Burger A. Langerhans cell precursors acquire RANK/CD265 in prenatal human skin. Acta Histochem (2015) 117(4-5):425-30. doi:10.1016/j.acthis.2015.01.003
88. Loser K, Mehling A, Loeser S, Apelt J, Kuhn A, Grabbe S, et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med (2006) 12(12):1372-9. doi:10.1038/nm1518
89. Fujimura T, Kambayashi Y, Furudate S, Kakizaki A, Hidaka T, Aiba S. Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget disease by receptor activator of nuclear factor kappa B (RANK) ligand/RANK pathways. Br J Dermatol (2017) 176(2):387-94. doi:10.1111/bjd.14864
90. Klenner L, Hafezi W, Clausen BE, Lorentzen EU, Luger TA, Beissert S, et al. Cutaneous RANK-RANKL signaling upregulates CD8-mediated antiviral immunity during herpes simplex virus infection by preventing virus-induced Langerhans cell apoptosis. J Invest Dermatol (2015) 135(11):2676-87. doi:10.1038/jid.2015.225
91. Condaminet B, Peguet-Navarro J, Stahl PD, Dalbiez-Gauthier C, Schmitt D, Berthier-Vergnes O. Human epidermal Langerhans cells express the mannose-fucose binding receptor. Eur J Immunol (1998) 28(11):3541-51. doi:10.1002/(SICI)1521-4141(199811)28:11<3541::AID-IMMU3541>3.0.CO;2-4
92. Flacher V, Bouschbacher M, Verronese E, Massacrier C, Sisirak V, Berthier-Vergnes O, et al. Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J Immunol (2006) 177(11):7959-67. doi:10.4049/jimmunol.177.11.7959
93. Hunger RE, Sieling PA, Ochoa MT, Sugaya M, Burdick AE, Rea TH, et al. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J Clin Invest (2004) 113(5):701-8. doi:10.1172/JCI200419655
94. Platzer B, Richter S, Kneidinger D, Waltenberger D, Woisetschlager M, Strobl H. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells. J Immunol (2009) 183(1):66-74. doi:10.4049/jimmunol.0802997
95. Stambach NS, Taylor ME. Characterization of carbohydrate recognition by langerin, a C-type lectin of Langerhans cells. Glycobiology (2003) 13(5):401-10. doi:10.1093/glycob/cwg045
96. Peiser M, Koeck J, Kirschning CJ, Wittig B, Wanner R. Human Langerhans cells selectively activated via toll-like receptor 2 agonists acquire migratory and CD4+ T cell stimulatory capacity. J Leukoc Biol (2008) 83(5):1118-27. doi:10.1189/jlb.0807567
97. Cheng CS, Feldman KE, Lee J, Verma S, Huang DB, Huynh K, et al. The specificity of innate immune responses is enforced by repression of interferon response elements by NF-kappaB p50. Sci Signal (2011) 4(161):ra11. doi:10.1126/scisignal.2001501
98. Ardouin L, Luche H, Chelbi R, Carpentier S, Shawket A, Montanana Sanchis F, et al. Broad and largely concordant molecular changes characterize tolerogenic and immunogenic dendritic cell maturation in thymus and periphery. Immunity (2016) 45(2):305-18. doi:10.1016/j.immuni.2016.07.019
99. Baratin M, Foray C, Demaria O, Habbeddine M, Pollet E, Maurizio J, et al. Homeostatic NF-kappaB signaling in steady-state migratory dendritic cells regulates immune homeostasis and tolerance. Immunity (2015) 42(4):627-39. doi:10.1016/j.immuni.2015.03.003
100. Borkowski TA, Letterio JJ, Farr AG, Udey MC. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J Exp Med (1996) 184(6):2417-22. doi:10.1084/jem.184.6.2417
101. Kaplan DH, Li MO, Jenison MC, Shlomchik WD, Flavell RA, Shlomchik MJ. Autocrine/paracrine TGFbeta1 is required for the development of epidermal Langerhans cells. J Exp Med (2007) 204(11):2545-52. doi:10.1084/jem.20071401
102. Zahner SP, Kel JM, Martina CA, Brouwers-Haspels I, van Roon MA, Clausen BE. Conditional deletion of TGF-betaR1 using Langerin-Cre mice results in Langerhans cell deficiency and reduced contact hypersensitivity. J Immunol (2011) 187(10):5069-76. doi:10.4049/jimmunol.1101880
103. Yasmin N, Konradi S, Eisenwort G, Schichl YM, Seyerl M, Bauer T, et al. beta-Catenin promotes the differentiation of epidermal Langerhans dendritic cells. J Invest Dermatol (2013) 133(5):1250-9. doi:10.1038/jid.2012.481
104. Xu YP, Shi Y, Cui ZZ, Jiang HH, Li L, Wang XF, et al. TGFbeta/Smad3 signal pathway is not required for epidermal Langerhans cell development. J Invest Dermatol (2012) 132(8):2106-9. doi:10.1038/jid.2012.71
105. Chopin M, Nutt SL. Establishing and maintaining the Langerhans cell network. Semin Cell Dev Biol (2015) 41:23-9. doi:10.1016/j.semcdb.2014.02.001
106. Zhang X, Gu J, Yu F-S, Zhou L, Mi Q-S. TGF-β1-induced transcription factor networks in Langerhans cell development and maintenance. Allergy (2016) 71:758-64. doi:10.1111/all.12871
107. Yarmus M, Woolf E, Bernstein Y, Fainaru O, Negreanu V, Levanon D, et al. Groucho/transducin-like enhancer-of-split (TLE)-dependent and-independent transcriptional regulation by Runx3. Proc Natl Acad Sci U S A (2006) 103(19):7384-9. doi:10.1073/pnas.0602470103
108. Fainaru O, Woolf E, Lotem J, Yarmus M, Brenner O, Goldenberg D, et al. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J (2004) 23(4):969-79. doi:10.1038/sj.emboj.7600085
109. van de Laar L, van den Bosch A, Wierenga AT, Janssen HL, Coffer PJ, Woltman AM. Tight control of STAT5 activity determines human CD34-derived interstitial dendritic cell and Langerhans cell development. J Immunol (2011) 186(12):7016-24. doi:10.4049/jimmunol.1003977
110. Iwama A, Osawa M, Hirasawa R, Uchiyama N, Kaneko S, Onodera M, et al. Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell commitment. J Exp Med (2002) 195(5):547-58. doi:10.1084/jem.20011465
111. Hacker C, Kirsch RD, Ju XS, Hieronymus T, Gust TC, Kuhl C, et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol (2003) 4(4):380-6. doi:10.1038/ni903
112. Heinz LX, Platzer B, Reisner PM, Jorgl A, Taschner S, Gobel F, et al. Differential involvement of PU.1 and Id2 downstream of TGF-beta1 during Langerhans-cell commitment. Blood (2006) 107(4):1445-53. doi:10.1182/blood-2005-04-1721
113. Cohen M, Matcovitch O, David E, Barnett-Itzhaki Z, Keren-Shaul H, Blecher-Gonen R, et al. Chronic exposure to TGFbeta1 regulates myeloid cell inflammatory response in an IRF7-dependent manner. EMBO J (2014) 33(24):2906-21. doi:10.15252/embj.201489293
114. Schridde A, Bain CC, Mayer JU, Montgomery J, Pollet E, Denecke B, et al. Tissue-specific differentiation of colonic macrophages requires TGFbeta receptor-mediated signaling. Mucosal Immunol (2017) 10(6):1387-99. doi:10.1038/mi.2016.142
115. Bain CC, Montgomery J, Scott CL, Kel JM, Girard-Madoux MJH, Martens L, et al. TGFbetaR signalling controls CD103+CD11b+ dendritic cell development in the intestine. Nat Commun (2017) 8(1):620. doi:10.1038/s41467-017-00658-6
116. Behar M, Hoffmann A. Understanding the temporal codes of intra-cellular signals. Curr Opin Genet Dev (2010) 20(6):684-93. doi:10.1016/j.gde.2010.09.007
117. Murphy TL, Grajales-Reyes GE, Wu X, Tussiwand R, Briseno CG, Iwata A, et al. Transcriptional control of dendritic cell development. Annu Rev Immunol (2016) 34:93-119. doi:10.1146/annurev-immunol-032713-120204
118. Jux B, Kadow S, Esser C. Langerhans cell maturation and contact hypersensitivity are impaired in aryl hydrocarbon receptor-null mice. J Immunol (2009) 182(11):6709-17. doi:10.4049/jimmunol.0713344
119. Marecki S, Riendeau CJ, Liang MD, Fenton MJ. PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene. J Immunol (2001) 166(11):6829-38. doi:10.4049/jimmunol.166.11.6829
120. Smith MA, Wright G, Wu J, Tailor P, Ozato K, Chen X, et al. Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation. J Biol Chem (2011) 286(10):7893-904. doi:10.1074/jbc. M110.165431
121. Kanno Y, Levi BZ, Tamura T, Ozato K. Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU.1 complex. J Interferon Cytokine Res (2005) 25(12):770-9. doi:10.1089/jir.2005.25.770
122. Escalante CR, Shen L, Escalante MC, Brass AL, Edwards TA, Singh H, et al. Crystallization and characterization of PU.1/IRF-4/DNA ternary complex. J Struct Biol (2002) 139(1):55-9. doi:10.1016/S1047-8477(02)00514-2
123. Hambleton S, Salem S, Bustamante J, Bigley V, Boisson-Dupuis S, Azevedo J, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med (2011) 365(2):127-38. doi:10.1056/NEJMoa1100066
124. Hoeffel G, Wang Y, Greter M, See P, Teo P, Malleret B, et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J Exp Med (2012) 209(6):1167-81. doi:10.1084/jem.20120340
125. Ginhoux F, Merad M. Ontogeny and homeostasis of Langerhans cells. Immunol Cell Biol (2010) 88(4):387-92. doi:10.1038/icb.2010.38
126. Chorro L, Sarde A, Li M, Woollard KJ, Chambon P, Malissen B, et al. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J Exp Med (2009) 206(13):3089-100. doi:10.1084/jem.20091586
127. Chorro L, Geissmann F. Development and homeostasis of 'resident' myeloid cells: the case of the Langerhans cell. Trends Immunol (2010) 31(12):438-45. doi:10.1016/j.it.2010.09.003